Overview

Increasing the throughput and efficiency of culture conditions is critical to improving biopharmaceutical yields and cutting costs. Continuous analysis of critical parameters in biopharmaceutical processing and manufacture holds the potential for dramatically improving product quality and reproducibility. However, ongoing challenges exist in the effort to develop methods that allow for the continuous feedback of product/manufacturing status.
This one and a half day premier meeting will discuss the technologies and techniques that can be applied to increase the optimization throughput of culture conditions for the field of bioprocessing.

Achieving Manufacturing Excellence and Reducing Speed-to-Clinic Using Innovative High-Throughput Bioprocessing Strategies Dr. Andrey J. Zarur, President & CEO, BioProcessors Corp.
Sessions Include:	Hear focused presentations from:
	Abbott Bioresearch Center Aegis Analytical Corporation BioProcessors Corp. Dowpharma, The Dow Chemical Company Intelligen, Inc. Lonza Biologics, UK Novartis Institutes for BioMedical Research sanofi-pasteur SRU Biosystems, Inc. Wyeth BioPharma

---